Cargando…
Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
INTRODUCTION: Virus and virus-like nanoparticles (VNPs) have been used for a variety of preclinical treatments, including in situ anti-cancer vaccination. The Cowpea mosaic virus (CPMV) is a VNP that has shown the ability to stimulate an anti-cancer immune response. The hypothesis of this study is t...
Autores principales: | Duval, Kayla E. A., Wagner, Robert J., Beiss, Veronique, Fiering, Steven N., Steinmetz, Nicole F., Hoopes, P. Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773968/ https://www.ncbi.nlm.nih.gov/pubmed/33392089 http://dx.doi.org/10.3389/fonc.2020.594614 |
Ejemplares similares
-
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
por: Stump, Courtney T., et al.
Publicado: (2021) -
Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity
por: Barreno, Lucia, et al.
Publicado: (2023) -
Radiation Therapy Combined with Cowpea Mosaic Virus
Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression
por: Patel, Ravi, et al.
Publicado: (2018) -
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022)